A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond

S Shapira, M Ben Shimon, M Hay‐Levi… - EMBO Molecular …, 2022 - embopress.org
A small but significant proportion of COVID‐19 patients develop life‐threatening cytokine
storm. We have developed a new anti‐inflammatory drug, EXO‐CD24, a combination of an …

[PDF][PDF] Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.

G Akkuzu, C Bes, DS Özgür… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: An increasing number of new on-set autoimmune-inflammatory rheumatic
diseases (AIRD) after COVID-19 vaccination has begun to be reported in the literature. In …

Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 Omicron variant infection: A retrospective study of 25207 …

P Ying-Hao, G Yuan-Yuan, Z Hai-Dong… - Frontiers in Cellular …, 2022 - frontiersin.org
Objectives To summarize the clinical characteristics of patients infected by SARS-CoV-2
omicron variant and explore the risk factors affecting the progression in a Fangcang hospital …

Unveiling COVID-19 secrets: Harnessing Cytokines as powerful biomarkers for diagnosis and predicting severity

B Wolszczak-Biedrzycka, J Dorf… - Journal of …, 2023 - Taylor & Francis
Introduction In coronavirus disease (COVID-19), inflammation takes center stage, with a
cascade of cytokines released, contributing to both inflammation and lung damage. The …

[HTML][HTML] Hemophagocytic syndrome and COVID-19: A comprehensive review

MM Fadlallah, SM Salman, MM Fadlallah, H Rahal - Cureus, 2023 - ncbi.nlm.nih.gov
Hemophagocytic lymphohistiocytosis (HLH), a hyperinflammatory hyperferritinemic
syndrome, is triggered by various etiologies and diseases and can lead to multiorgan …

IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition

BS Haslund-Gourley, K Woloszczuk, J Hou… - Nature …, 2024 - nature.com
The glycosylation of IgG plays a critical role during human severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing …

[HTML][HTML] Effectiveness of molnupiravir treatment in patients with COVID-19 in Korea: a propensity score matched study

HR Park, MG Yoo, JM Kim, SJ Bae, H Lee… - Infection & …, 2023 - ncbi.nlm.nih.gov
Background The MOVe-OUT (efficacy and safety of molnupiravir [MK-4482] in non-
hospitalized adult participants with COVID-19 [MK-4482-002]) trial reported that the …

Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection

T Lu, Q Man, X Yu, S Xia, L Lu, S Jiang… - Frontiers in …, 2023 - frontiersin.org
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant has prevailed globally since November 2021. The extremely high transmissibility and …

Mechanism and Experimental Verification of the Use of Rhodiola crenulata to Cytokine Storm Based on Network Pharmacology and Molecular Docking

W Zhao, D Song, P Wang, Y Tian… - Natural Product …, 2022 - journals.sagepub.com
Objective: To identify the potential biological mechanisms by which Rhodiola crenulata (RC)
treats cytokine storm (CS) using network pharmacology, molecular docking, and …

COVID-19 biology: cytokine storms and their implications

N Atceken, G Kozalak - Stem Cells, 2024 - Elsevier
COVID-19 disease presents in asymptomatic and various symptomatic forms among
individuals. It is thought to be caused by the immune response of individuals. In severe and …